HomeCompareMGRM vs PEP

MGRM vs PEP: Dividend Comparison 2026

MGRM yields 33.33% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGRM wins by $18.2K in total portfolio value
10 years
MGRM
MGRM
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full MGRM calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — MGRM vs PEP

📍 MGRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGRMPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGRM + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGRM pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGRM
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $32,871.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGRM + PEP for your $10,000?

MGRM: 50%PEP: 50%
100% PEP50/50100% MGRM
Portfolio after 10yr
$151.0K
Annual income
$42,539.60/yr
Blended yield
28.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

MGRM
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$5.40
-10.0% upside vs current
Range: $5.40 — $5.40
Altman Z
12.6
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGRM buys
0
PEP buys
0
No recent congressional trades found for MGRM or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGRMPEP
Forward yield33.33%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$160.1K$141.9K
Annual income after 10y$23,203.52$61,875.67
Total dividends collected$113.6K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$5.40$172.43

Year-by-year: MGRM vs PEP ($10,000, DRIP)

YearMGRM PortfolioMGRM Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$14,033$3,333.33$10,849$509.42+$3.2KMGRM
2$19,387$4,371.75$11,969$750.47+$7.4KMGRM
3$26,389$5,644.57$13,500$1,124.14+$12.9KMGRM
4$35,417$7,180.46$15,680$1,721.66+$19.7KMGRM
5$46,902$9,006.44$18,929$2,715.34+$28.0KMGRM
6$61,333$11,146.93$24,023$4,450.80+$37.3KMGRM
7$79,249$13,622.82$32,510$7,669.92+$46.7KMGRM
8$101,247$16,450.69$47,709$14,093.60+$53.5KMGRM
9$127,976$19,642.17$77,415$28,083.48+$50.6KMGRM
10$160,138$23,203.52$141,922$61,875.67+$18.2KMGRM

MGRM vs PEP: Complete Analysis 2026

MGRMStock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Full MGRM Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this MGRM vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGRM vs SCHDMGRM vs JEPIMGRM vs OMGRM vs KOMGRM vs MAINMGRM vs MOMGRM vs PMMGRM vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.